Related references
Note: Only part of the references are listed.Acute kidney injury in patients treated with anti-programmed death receptor-1 for advanced melanoma: a real-life study in a single-centre cohort
Claire Stein et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2021)
Timing of Recovery From Moderate to Severe AKI and the Risk for Future Loss of Kidney Function
Edward D. Siew et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2020)
Clinical Features and Outcomes of Immune Checkpoint Inhibitor-Associated AKI: A Multicenter Study
Frank B. Cortazar et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2020)
The Future of Immunotherapy-Based Combination Therapy in Metastatic Renal Cell Carcinoma
Rohan Garje et al.
CANCERS (2020)
Immunotherapy in Bladder Cancer: Current Methods and Future Perspectives
Mikolaj Wolacewicz et al.
CANCERS (2020)
Incidence and Clinical Features of Immune-Related Acute Kidney Injury in Patients Receiving Programmed Cell Death Ligand-1 Inhibitors
Harish Seethapathy et al.
KIDNEY INTERNATIONAL REPORTS (2020)
Association Between Immune Checkpoint Inhibitors With Cardiovascular Events and Atherosclerotic Plaque
Zsofia D. Drobni et al.
CIRCULATION (2020)
Acute Kidney Injury in Patients Receiving Systemic Treatment for Cancer: A Population-Based Cohort Study
Abhijat Kitchlu et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2019)
Incident Chronic Kidney Disease After Radical Nephrectomy for Renal Cell Carcinoma
Robert J. Ellis et al.
CLINICAL GENITOURINARY CANCER (2019)
Diagnosis and Management of Immune Checkpoint Inhibitor-Associated Renal Toxicity: Illustrative Case and Review
Meghan E. Sise et al.
ONCOLOGIST (2019)
Acute kidney injury and long-term renal function after partial nephrectomy-is there a true association?
Won Ho Kim et al.
ANNALS OF TRANSLATIONAL MEDICINE (2019)
The Incidence, Causes, and Risk Factors of Acute Kidney Injury in Patients Receiving Immune Checkpoint Inhibitors
Harish Seethapathy et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2019)
Cabozantinib in Combination with Immunotherapy for Advanced Renal Cell Carcinoma and Urothelial Carcinoma: Rationale and Clinical Evidence
Paulo Bergerot et al.
MOLECULAR CANCER THERAPEUTICS (2019)
Acute kidney injury in the patient with cancer
Mitchell H. Rosner et al.
KIDNEY RESEARCH AND CLINICAL PRACTICE (2019)
Incident CKD after Radical or Partial Nephrectomy
John T. Leppert et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2018)
End-Stage Kidney Disease following Surgical Management of Kidney Cancer
Robert J. Ellis et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2018)
Checkpoint Inhibitors in Patients With Metastatic Renal Cell Carcinoma: Results From the International Metastatic Renal Cell Carcinoma Database Consortium
Steven M. Yip et al.
CANCER (2018)
Immunotherapy in genitourinary malignancies
Max M. Wattenberg et al.
CURRENT OPINION IN UROLOGY (2016)
Trends of acute kidney injury after radical or partial nephrectomy for renal cell carcinoma
Marianne Schmid et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2016)
Acute Kidney Injury in the Cancer Patient
G. Adam Campbell et al.
ADVANCES IN CHRONIC KIDNEY DISEASE (2014)
Cancer and renal insufficiency results of the BIRMA study
N. Janus et al.
BRITISH JOURNAL OF CANCER (2010)
A New Equation to Estimate Glomerular Filtration Rate
Andrew S. Levey et al.
ANNALS OF INTERNAL MEDICINE (2009)
Prevalence of renal insufficiency in cancer patients and implications for anticancer drug management - The renal insufficiency and anticancer medications (IRMA) study
Vincent Launay-Vacher et al.
CANCER (2007)
Incidence of renal insufficiency in cancer patients
E Dogan et al.
ADVANCES IN THERAPY (2005)
Share Paper
